Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/edqXCfbwoceXamvJZmal

December 26, 2012
Sign upForwardArchive
Your resource for current wound care information

  Wound Care Update 
  • Study yields promising results for skin infection drug
    The antibiotic oritavancin performed comparably with standard-of-care vancomycin in terms of efficacy, according to findings from a late-stage trial. The drug met the primary endpoint of the study, which was to halt the spread of the infection and to eliminate fever. The drug was tested for the treatment of acute bacterial skin and skin structure infections by gram-positive bacteria, including methicillin-resistant Staphylococcus aureus. Reuters (12/20) LinkedInFacebookTwitterEmail this Story
  Research, Technology & Innovation 
  Health Policy & Regulation 
Learn more about ADVTIS ->Advanced Tissue  |  Meet Our People
Placing An Order  |  Why Use Advanced Tissue
Our Philosophy  |  Facebook

  SmartQuote 
Never get so fascinated by the extraordinary that you forget the ordinary."
--Magdalen Nabb,
British author


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

 
Contact Advanced Tissue
7003 Valley Ranch Drive
Little Rock, Arkansas 72223
1-866-217-9900
www.advtis.com
info@advtis.com
 
Quick Links
Why Use Advanced Tissue

Our Philosophy

Meet Our People

Placing An Order

Facebook
 
About Advanced Tissue
Advanced Tissue is a leading wound care supply company offering a comprehensive line of wound care products from virtually all manufacturers. We understand the many obstacles associated with effective wound treatment and use this insight to provide the efficient delivery of dressings to enable enhanced compliance and improved patient outcomes. Advanced Tissue works with clinics throughout the U.S. and its territories to deliver a turnkey wound-supply solution for patients in the home setting as well as long-term care residents. Unit Dose Packaging provides a daily supply of advanced wound dressings packaged in an easy-open package. Our relationship with clinicians in the industry was forged on our innovative delivery model of Unit Dose Packaging and our commitment to not substituting product for financial gain. The ease and simplicity of this system has established Advanced Tissue as an invaluable partner in wound care.

 
 Recent Advanced Tissue SmartBrief Issues:   Lead Editor:  Kathryn Doherty
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information